How to make more cancers vulnerable to immunotherapies
Cancer immunotherapies called checkpoint inhibitors can bring dramatic, life-saving results – but only for a limited fraction of patients. Aiming to help more patients benefit, researchers in...
Tag: clinical trials
Expanding access to experimental cancer treatments in Oregon: Q&A with Shivaani Kummar
This week, the OHSU Knight Cancer Institute opened a new, 13,000-square-foot space devoted to serving patients taking part in early-phase clinical trials. The unit completes the build-out of the...
Making cancer clinical trials more relevant
When a new cancer drug improves survival in a clinical trial, it too often remains unclear whether the drug will be effective in clinical practice, asserts a provocative commentary (co-authored by an...
Shortcut clinical trials may be misleading oncologists
Among 55 cancer drugs recently approved on the basis of a surrogate endpoint, less than one-fifth have been shown to improve survival in follow-up clinical trials. Fully two-thirds of new cancer...